[{"address1": "Building 7", "address2": "Kiryat Atidim", "city": "Tel Aviv", "zip": "6158002", "country": "Israel", "phone": "972 77 331 0156", "website": "https://www.chemomab.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is CM-101, a humanized monoclonal antibody attenuates the basic function of CCL24 that is in phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Adi Mor George Ph.D.", "age": 41, "title": "Co-Founder, Chief Scientific Officer, CEO & Executive Director", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sigal  Fattal CPA, M.B.A.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 322000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew B. Frankel M.B.A., M.D.", "age": 54, "title": "Chief Medical Officer & VP of Drug Development", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 850000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Barbara  Lindheim", "title": "Consulting Vice President of Investor & Public Relations, Strategic Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jack  Lawler", "title": "Senior VP of Global Clinical Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.01, "open": 1.022, "dayLow": 0.87, "dayHigh": 1.022, "regularMarketPreviousClose": 1.01, "regularMarketOpen": 1.022, "regularMarketDayLow": 0.87, "regularMarketDayHigh": 1.022, "beta": 0.207, "forwardPE": -23.3325, "volume": 135586, "regularMarketVolume": 135586, "averageVolume": 137188, "averageVolume10days": 93690, "averageDailyVolume10Day": 93690, "bid": 0.8705, "ask": 0.9645, "bidSize": 100, "askSize": 100, "marketCap": 13270593, "fiftyTwoWeekLow": 0.42, "fiftyTwoWeekHigh": 1.58, "fiftyDayAverage": 1.078, "twoHundredDayAverage": 0.766795, "currency": "USD", "enterpriseValue": 249924816, "floatShares": 188128719, "sharesOutstanding": 14219000, "sharesShort": 105014, "sharesShortPriorMonth": 99698, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0074, "heldPercentInsiders": 0.11566, "heldPercentInstitutions": 0.18417, "shortRatio": 1.6, "shortPercentOfFloat": 0.0075, "impliedSharesOutstanding": 11254500, "bookValue": 0.938, "priceToBook": 0.99498934, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -19336000, "trailingEps": -1.54, "forwardEps": -0.04, "lastSplitFactor": "1:16", "lastSplitDate": 1615939200, "enterpriseToEbitda": -12.257, "52WeekChange": -0.17433625, "SandP52WeekChange": 0.19031036, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CMMB", "underlyingSymbol": "CMMB", "shortName": "Chemomab Therapeutics Ltd.", "longName": "Chemomab Therapeutics Ltd.", "firstTradeDateEpochUtc": 1549981800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f2fd6842-2d35-37be-bf48-b334c1a2bb54", "messageBoardId": "finmb_323539890", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.9333, "targetHighPrice": 13.0, "targetLowPrice": 4.0, "targetMeanPrice": 8.67, "targetMedianPrice": 9.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 15877000, "totalCashPerShare": 0.056, "ebitda": -20390250, "totalDebt": 390000, "quickRatio": 3.811, "currentRatio": 3.828, "debtToEquity": 2.926, "returnOnAssets": -0.48229998, "returnOnEquity": -0.93671, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-11"}]